000 | 01930 a2200613 4500 | ||
---|---|---|---|
005 | 20250517125611.0 | ||
264 | 0 | _c20170518 | |
008 | 201705s 0 0 eng d | ||
022 | _a1475-2875 | ||
024 | 7 |
_a10.1186/s12936-016-1634-6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRavenhall, Matt | |
245 | 0 | 0 |
_aCharacterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi. _h[electronic resource] |
260 |
_bMalaria journal _cNov 2016 |
||
300 |
_a575 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntimalarials _xtherapeutic use |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aDrug Combinations |
650 | 0 | 4 | _aDrug Resistance |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Frequency |
650 | 0 | 4 | _aGenetic Variation |
650 | 0 | 4 | _aGenome, Protozoan |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aMalaria, Falciparum _xdrug therapy |
650 | 0 | 4 | _aMalawi |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aPlasmodium falciparum _xclassification |
650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
650 | 0 | 4 |
_aPyrimethamine _xtherapeutic use |
650 | 0 | 4 | _aSelection, Genetic |
650 | 0 | 4 | _aSequence Analysis, DNA |
650 | 0 | 4 |
_aSulfadoxine _xtherapeutic use |
700 | 1 | _aBenavente, Ernest Diez | |
700 | 1 | _aMipando, Mwapatsa | |
700 | 1 | _aJensen, Anja T R | |
700 | 1 | _aSutherland, Colin J | |
700 | 1 | _aRoper, Cally | |
700 | 1 | _aSepĂșlveda, Nuno | |
700 | 1 | _aKwiatkowski, Dominic P | |
700 | 1 | _aMontgomery, Jacqui | |
700 | 1 | _aPhiri, Kamija S | |
700 | 1 | _aTerlouw, Anja | |
700 | 1 | _aCraig, Alister | |
700 | 1 | _aCampino, Susana | |
700 | 1 | _aOcholla, Harold | |
700 | 1 | _aClark, Taane G | |
773 | 0 |
_tMalaria journal _gvol. 15 _gno. 1 _gp. 575 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12936-016-1634-6 _zAvailable from publisher's website |
999 |
_c26650482 _d26650482 |